Medpace Holdings revenue and financials
$602.90Change from previous close: −2.84%Absolute change: −$17.61
In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +19.97%
- 2025 vs 2024
- Net income growth
- +11.56%
- 2025 vs 2024
- Net margin
- 17.8%
- 2024: 19.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 713 | 609 | 433 | 388 | 263 | 259 | 202 | 157 | 97.4 | 91.7 |
| Depreciation and amortization | 27.2 | 27.8 | 24.1 | 19.0 | 16.0 | 11.7 | 8.4 | 9.2 | 8.6 | 7.4 |
| Capital expenditure | -31.4 | -36.5 | -36.6 | -36.9 | -28.3 | -31.3 | -17.9 | -16.0 | -11.7 | -13.5 |
| Investing cash flow | -31.1 | -28.3 | -34.6 | -38.7 | -31.4 | — | — | — | — | — |
| Financing cash flow | -860 | -154 | -183 | -776 | -44.5 | — | — | — | — | — |
| Share repurchases | -917 | -170 | -144 | -848 | -62.1 | -98.3 | 0.0 | 0.0 | -156 | 0.0 |
| Debt issued | 0.0 | 0.0 | 105 | 324 | — | — | — | — | — | — |
| Debt repaid | 0.0 | 0.0 | -155 | -274 | — | — | — | — | — | — |
| Effect of exchange rates | 5.9 | -2.5 | 1.1 | -6.6 | -4.0 | — | — | — | — | — |
| Net change in cash | -172 | 424 | 217 | -433 | 184 | — | — | — | — | — |
| Free cash flow | 682 | 572 | 397 | 351 | 235 | — | — | — | — | — |
| Levered free cash flow | 472 | 465 | 346 | 296 | 214 | — | — | — | — | — |